Dr. Virin Rajiv Neil Ramoutar, MD

Dr. Ramoutar practices at Wellstar MCG Health Medical Center in Augusta, Georgia, part of Wellstar Health System.

Dr. Ramoutar's NPI, 1891059408, was assigned on June 28, 2012. Dr. Ramoutar holds Georgia license 97810.

Dr. Ramoutar's primary practice is Wellstar MCG Health Medical Center, at 1120 15th Street, Augusta, GA 30912 in Richmond County. The practice phone is (706) 721-6569.

Dr. Ramoutar's primary practice is Wellstar MCG Health Medical Center in Augusta, Georgia, part of Wellstar Health System. The medical group on file is Wellstar Medical Group. Dmand AI also links Dr. Ramoutar to 2 more dialysis centers and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ramoutar practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Ramoutar's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Ramoutar's licenses on file in 3 states: Georgia, Florida and Tennessee.

CMS data shows 489 Medicare services from Dr. Ramoutar across 7 procedure codes in 2024, for 218 Medicare patients. Medicare paid $49,464 for them.

CMS counts 218 Medicare patients who saw Dr. Ramoutar in 2024. The largest group is 65 to 74, with 97 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 30% are also on Medicaid. Their average risk score is 5.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ramoutar's median patient age at 69, with 62% women.

In 2024, Dr. Ramoutar wrote 206 Medicare Part D claims for 58 patients. 75% of them were for generic drugs. CMS names the drug for 70 of them, across 4 drugs with 11 or more claims each, at $20,334 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Ramoutar for performance year 2024, reported through an alternative payment model (APM). Dr. Ramoutar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Ramoutar, published from 2011 to 2025. 2014 was the busiest year, with 2. Dr. Ramoutar has published most often in BMJ Case Rep. Dr. Ramoutar's most frequent co-authors are William Russell Cullinane, DO, Melissa Dakkak, DO and Leighton Rolston James, MD.

CMS Open Payments shows 54 general payments to Dr. Ramoutar from 25 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 94% of the total. Mallinckrodt Enterprises LLC paid the most, $288.